Talbot and colleagues establish a link between brain insulin resistance in AD cases and reduced responses to insulin signaling and IGF-1 resistance, contributing to cognitive decline independently of classic AD pathology.9 This highlights IGF-1's role in brain function and its impact on cognitive outcomes. The gene discussed is IGF1; the disease is Alzheimer disease.